₹329.35
as on
as on September 8, 2025 at 4:01 pm IST
Day's Low
Day's High
2.52%
Downside
1.87%
Upside
52 Week's Low
52 Week's High
36.21%
Downside
15.62%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹739.48 Cr
Return on Equity (ROE)
5.36
PE Ratio (TTM)
36.85
Return on capital employed (ROCE)
7.36
Industry PE ratio
42.41
Beta (LTM)
0.67
P/B Ratio
3.11
Dividend Yield
0PEG Ratio
9.7
Quarterly Earnings Growth YOY
93.78
EPS (TTM)
5.37
Sector
Pharmaceuticals
Book Value
118.41
Technical Analysis
Bullish
View Technical Analysis
as on September 8, 2025 at 4:01 pm IST
Sakar Healthcare Ltd in the last 5 years
Lowest (13.06x)
May 12, 2022
Today (36.85x)
September 5, 2025
Industry (42.41x)
September 5, 2025
Highest (71.76x)
January 24, 2024
Today’s Price to Earnings Ratio: 36.85x
Compare market cap, revenue, PE, and other key metrics of Sakar Healthcare Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 739.48 | 75.43% | 0.62 | 11 | 153 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Sakar Healthcare Ltd Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Sakar Healthcare Ltd.
Sakar Healthcare Ltd’s net profit jumped 93.78% since last year same period to ₹4.67Cr in the Q1 2025-2026. On a quarterly growth basis, Sakar Healthcare Ltd has generated -18.92% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, SAKAR stock has moved up by 30.3%
Revenue Rich
Revenue is up for the last 5 quarters, 41.61 Cr → 53.13 Cr (in ₹), with an average increase of 5.8% per quarter
Retail Holding Up
Retail Investor have increased holdings from 21.85% to 22.48% in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 16.2% return, outperforming this stock by 13.1%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 89.4%
FII Holding Down
Foreign Institutions have decreased holdings from 13.61% to 13.41% in Jun 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 53.58% to 52.86% in Jun 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 5.76 Cr → 4.67 Cr (in ₹), with an average decrease of 18.9% per quarter
Organisation | Sakar Healthcare Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
CEO | Sanjay S Shah. |
E-voting on shares | Click here to vote |
Sakar Healthcare Ltd share price today stands at ₹329.35 as on at the close of the market. Sakar Healthcare Ltd share today touched a day high of ₹335.5 and a low of ₹321.05.
Sakar Healthcare Ltd touched a 52 week high of ₹380.8 and a 52 week low of ₹210.1. Sakar Healthcare Ltd share price today i.e. is closed at ₹329.35, which is -13.51% down from its 52 week high and 56.76% up from its 52 week low.
Sakar Healthcare Ltd market capitalisation is ₹739.48 Cr as on .
To buy Sakar Healthcare Ltd shares, you need to follow these steps:
Sakar Healthcare Ltd trading volume is 20.20K as on . This means that 20.20K shares of Sakar Healthcare Ltd were bought and sold on the stock market during today's trading session.